Summit Therapeutics Inc.
Summit Therapeutics Inc.（SMMT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
smmt · 股价预测 · 21 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 21 位华尔街分析师
Buy
21 位分析师
共识
评级分布
12 个月目标价
High
$23.00
Consensus
$19.00
+28.6% upside
Low
$16.00
Median: $18 · Last Close: $14.77
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.00
28.6% upside
High Target
$23
55.7%
Low Target
$16
8.3%
Current Price
$14.77
as of today
Based on analyst price targets, the SMMT stock price prediction for the next 12 months ranges from $16 to $23. The consensus SMMT price forecast of $19.00 implies 28.6% upside from the current price of $14.77.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.03 | ↓ 5.00% |
1-day model range: $13.87–$14.2. Peak: $14.2 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +23.2% |
| 2028 | $21 | +41.7% |
| 2029 | $23 | +55.5% |
| 2030 | $24 | +65.4% |
| 2031 | — | +72.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SMMT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-01 | Piper Sandler | Maintains | Neutral→Neutral |
| 2026-04-08 | Stifel | Maintains | Buy→Buy |
| 2026-03-16 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-30 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-17 | Barclays | Upgrade ↑ | Underweight→Equal Weight |
| 2025-10-22 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Summit Therapeutics Inc. (SMMT) stock. Of the recent 59 rating actions, 2 were upgrades and 8 were downgrades. 21 analysts currently cover SMMT.
分析师推荐趋势
SMMT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4M
↓ 99.5% YoY
Revenue Next Year
$78M
↑ 1973.8% YoY
EPS This Year
$-1.13
EPS Next Year
$-1.13
↑ 0.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast SMMT EPS of $-1.13 for the current fiscal year, based on estimates from 8 analysts. The SMMT revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SMMT 股价预测由两类独立数据源支撑：来自 21 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SMMT 的共识目标价为 $19.00（+28.6% 上行空间），分析师共识为 Buy。
SMMT 的短期预测（明日）为 $14.03（-5.00%）。 SMMT 对 2027 年的股价预测均值为 $18。 SMMT 对 2030 年的预测区间为 $21–$28。
Summit Therapeutics Inc. 在 NASDAQ 上市，代码 SMMT。SMMT 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
SMMT 预测 · 8 个问题根据 21 位华尔街分析师，SMMT 的 12 个月平均目标价为 $19.00，最高 $23.00、最低 $16.00。若有图表，中位目标价可在上方查看。相对当前价 $14.77，隐含约 +28.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.